Parker Michael Andrew 13D and 13G filings for Arch Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 12:39 pm Purchase | 2023-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 213,529 4.500% | 107,340 (+101.08%) | Filing |
| 2023-01-27 2:18 pm Unchanged | 2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 106,189 8.497% | 0 (Unchanged) | Filing |
| 2023-01-25 3:18 pm Purchase | 2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 106,189 8.497% | 106,189 (New Position) | Filing |